8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A prescriber-level guide to recognizing, grading, and managing adverse events from systemic estrogen therapy, covering VTE, endometrial risk, cardiovascular effects, and monitoring protocols with evidence from WHI, PEPI, and current NAMS/ACOG guidelines.
A prescriber-level guide to the systemic estrogens drug class: formulations, dosing, menopausal HRT indications, and a practical step-by-step billing and prior-authorization workflow for 2024 to 2025.
A prescriber-level monograph on systemic estrogens: pharmacology, formulations, dosing, indications, contraindications, monitoring, and key trial data for menopausal HRT and beyond.
A clinician-focused drug-drug interaction reference for systemic estrogens, covering CYP3A4 inducers, thyroid binding changes, anticoagulant effects, and management strategies for estradiol, conjugated estrogens, and ethinyl estradiol.
A clinical-level review of the systemic estrogens drug class, covering monitoring parameters, dosing, safety signals, and prescribing guidance for oral, transdermal, and injectable estradiol formulations.
A prescribing-level review of systemic estrogens across special populations, including postmenopausal women, surgical menopause, cardiovascular risk, breast cancer survivors, and more. Covers dosing, contraindications, and guideline-based recommendations.
Evidence-based titration and tapering protocols for systemic estrogen therapy in menopausal hormone replacement, including oral estradiol, transdermal patches, and conjugated estrogens. Written for prescribers and dispensing pharmacists.
A clinical-level guide to systemic estrogen formulations, routes, doses, and patient-selection logic for menopausal HRT. Written for prescribers and dispensing pharmacists.